eastham in A Sentence

    1

    Dr. Eastham: We think so.

    0
    2

    Dr. Eastham: Yes, it's exactly the same pathology.

    0
    3

    Dick: Dr. Eastham mentioned some of those.

    0
    4

    Dr. Eastham: It has to do with the environment.

    0
    5

    Dr. Eastham: Certainly, it's safe to mix these drugs.

    0
    6

    Dr. Eastham: Newer modalities are going to become available.

    0
    7

    Dr. Eastham: The common theme in both of those treatments is intravenous bisphosphonates.

    0
    8

    Dr. Eastham: If they're going to be on long-term hormonal therapy, they should be.

    0
    9

    Dr. Eastham: With the way that it's currently given, the risk of kidney malfunction is very rare.

    0
    10

    Dr. Eastham: In some of the studies, they actually have been shown to increase bone mineral density.

    0
    11

    Dr. Eastham: Unfortunately, as with many medical conditions, you really don't know you have it until there's been a bad event.

    0
    12

    Dr. Eastham: Bisphosphonates are a category of medications that inhibit one of the bone cells, called an osteoclast, that eats up bone.

    0
    13

    Dr. Eastham: When a cancer cell invades the bone, the type of lesion it establishes will depend on how it interacts with the bone cells.

    0
    14

    Dr. Eastham: It's been known for quite some time now, but the indications or the length of time that men are on androgen-deprivation therapy[hormone therapy for prostate cancer] is increasing.

    0
    15

    Dr. Eastham: We are looking at the role of intravenous bisphosphonates as a preventer of the establishment of metastatic disease in the bones, so that's certainly an area of active research.

    0
    16

    Dr. Eastham: Just being informed, I think, is the most critical aspect of being proactive about one's health, and discussing these issues with your healthcare team, making sure that they understand that bone health is important.

    0
    17

    Dr. Eastham: Yes, it took a while for us to realize that bone loss was an issue for men with prostate cancer and as new therapies became available and were being investigated, I was involved in some trials that evaluated their potential impact on patients' health.

    0